Shawah Robert G. has filed 4 insider transactions across 1 company since February 2023.
Most recent transaction: a grant/award of 25900 shares of Acurx Pharmaceuticals, Inc. ($ACXP) on April 20, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 20, 2026 | Acurx Pharmaceuticals, Inc. | $ACXP | Shawah Robert G. | Chief Financial Officer | A | Stock Option | 25900 | $0.00 | 25,900.0000 | 1,498,793 | 9999.99% | 1.73% |
| Feb. 5, 2025 | Acurx Pharmaceuticals, Inc. | $ACXP | Shawah Robert G. | Chief Financial Officer | A | Stock Option | 145500 | $0.00 | 145,500.0000 | 16,163,366 | 9999.99% | 0.90% |
| Feb. 23, 2024 | Acurx Pharmaceuticals, Inc. | $ACXP | Shawah Robert G. | Chief Financial Officer | A | Stock Option | 145000 | $0.00 | 145,000.0000 | 12,671,572 | 9999.99% | 1.14% |
| Feb. 13, 2023 | Acurx Pharmaceuticals, Inc. | $ACXP | Shawah Robert G. | Chief Financial Officer | A | Stock Option | 75000 | $0.00 | 75,000.0000 | 10,816,412 | 9999.99% | 0.69% |